National Research (NRC) to Announce Earnings on Tuesday

National Research (NASDAQ:NRCGet Free Report) is expected to be releasing its Q2 2026 results before the market opens on Tuesday, July 28th. Analysts expect National Research to post earnings of ($0.15) per share and revenue of $34.90 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Tuesday, August 4, 2026 at 10:00 AM ET.

National Research (NASDAQ:NRCGet Free Report) last posted its earnings results on Tuesday, April 28th. The company reported $0.21 earnings per share for the quarter. National Research had a net margin of 6.52% and a return on equity of 122.73%. The business had revenue of $34.80 million for the quarter.

National Research Stock Performance

NASDAQ:NRC opened at $21.04 on Monday. The firm has a market capitalization of $478.66 million, a PE ratio of 53.95 and a beta of 0.35. The company has a quick ratio of 0.52, a current ratio of 0.52 and a debt-to-equity ratio of 5.48. National Research has a 12-month low of $11.01 and a 12-month high of $23.00. The firm has a 50-day moving average price of $20.33 and a 200 day moving average price of $18.29.

Institutional Investors Weigh In On National Research

A number of hedge funds have recently made changes to their positions in the company. EverSource Wealth Advisors LLC lifted its holdings in National Research by 9,535.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company’s stock valued at $28,000 after purchasing an additional 1,621 shares during the last quarter. Russell Investments Group Ltd. grew its stake in National Research by 85.6% during the third quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock worth $26,000 after buying an additional 921 shares during the last quarter. Raymond James Financial Inc. bought a new stake in National Research during the second quarter worth about $34,000. BNP Paribas Financial Markets increased its holdings in shares of National Research by 85.4% during the third quarter. BNP Paribas Financial Markets now owns 2,496 shares of the company’s stock worth $32,000 after buying an additional 1,150 shares in the last quarter. Finally, Quadrant Capital Group LLC increased its holdings in shares of National Research by 315.9% during the fourth quarter. Quadrant Capital Group LLC now owns 2,583 shares of the company’s stock worth $48,000 after buying an additional 1,962 shares in the last quarter. Institutional investors and hedge funds own 47.26% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on NRC shares. Weiss Ratings upgraded National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. Citizens Jmp initiated coverage on National Research in a research report on Monday, June 22nd. They set a “market outperform” rating and a $23.00 target price for the company. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $23.00.

View Our Latest Report on NRC

National Research Company Profile

(Get Free Report)

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.

Featured Articles

Earnings History for National Research (NASDAQ:NRC)

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.